Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationBone and BonesTransplantation ConditioningAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationMice, Inbred C57BLRecurrenceHematopoiesisCombined Modality TherapyHematologic NeoplasmsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsBone Marrow ExaminationTime FactorsRemission InductionGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyBone RemodelingImmunosuppressionT-LymphocytesBone Marrow NeoplasmsLymphocyte DepletionLeukemia, MyeloidGraft vs Host ReactionStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyHLA AntigensRetrospective StudiesSurvival AnalysisMyelodysplastic SyndromesChimeraColony-Forming Units AssayHematologic DiseasesLung TransplantationCyclosporineLymphocyte TransfusionActuarial AnalysisBone DensityMice, Inbred BALB CGraft vs Leukemia EffectSpleenAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectOrgan TransplantationCytomegalovirus InfectionsCell DifferentiationNuclear FamilyFollow-Up StudiesCarmustineSurvival RateLeukocyte CountFlow CytometryPancytopeniaCytarabineImmune SystemDisease-Free SurvivalCells, CulturedMelphalanBone ResorptionGranulocyte Colony-Stimulating FactorLymphomaMultiple MyelomaMice, KnockoutImmune ToleranceEtoposideInfectionFatal OutcomeChimerismAntilymphocyte SerumCord Blood Stem Cell TransplantationPrognosis